EE170 A Cost-Effectiveness Analysis, with Public Healthcare Payers’ Perspective, of Oral Semaglutide Versus Luseogliflozin Hydrate for Patients with Type 2 Diabetes Mellitus in a Japanese Clinical Setting
Abstract
Authors
R. Ota K. Fujiwara H. Matsuda K. Idehara A. Igarashi